AtriCure, Inc. (NASDAQ:ATRC)

CAPS Rating: 4 out of 5

The Company develops, manufactures and sells innovative surgical devices designed to create precise lesions, or scars, in cardiac and soft tissues.

Recs

0
Player Avatar Fiskhus (71.97) Submitted: 7/10/2012 8:37:26 PM : Outperform Start Price: $9.60 ATRC Score: -24.81

T3A C<$10 and C>maxH3.1 and s50A&20.1V

Featured Broker Partners


Advertisement